The Trump administration is reviewing Harvard’s patents under the Bayh-Dole Act, accusing the university of mishandling federally funded research inventions.

Harvard must report all related patents by September 5, 2025.

The patents, worth potentially hundreds of millions, involve biotech, medicine, and engineering.

Harvard calls the probe politically motivated. Other Ivy League schools have settled similar disputes to restore federal funding access.

This review could affect federally funded research at top universities nationwide.